Ticker Details
Enanta Pharmaceuticals, Inc. Enanta Pharmaceuticals Inc is a biotechnology company. It is engaged in the research and development of small molecule drugs for infectious diseases. The Group uses its chemistry-driven approach & drug discovery capabilities to develop its products.
IPO Date:	March 21, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$360.49M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.90 | 2.28%
Avg Daily Range (30 D):	$0.43 | 2.95%
Avg Daily Range (90 D):	$0.45 | 4.18%

Institutional Daily Volume
Avg Daily Volume:	.2M
Avg Daily Volume (30 D):	.24M
Avg Daily Volume (90 D):	.53M

Trade Size
Avg Trade Size (Sh.):	72
Avg Trade Size (Sh.) (30 D):	48
Avg Trade Size (Sh.) (90 D):	74

Institutional Trades
Total Institutional Trades:	2,626
Avg Institutional Trade:	$1.78M
Avg Institutional Trade (30 D):	$1.7M
Avg Institutional Trade (90 D):	$1.34M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.92M
Avg Closing Trade (30 D):	$2.14M
Avg Closing Trade (90 D):	$1.73M
Avg Closing Volume:	39.27K

News

Sep 29, 2025 @ 5:35 PM 10 Health Care Stocks With Whale Alerts In Today's... Source: Benzinga Staff Writer

Sep 29, 2025 @ 5:28 PM Enanta's RSV Pill Shows Promise In Cutting Recover... Source: Vandana Singh

Sep 29, 2025 @ 5:06 PM 12 Health Care Stocks Moving In Monday's Intraday ... Source: Benzinga Staff Writer

Sep 26, 2025 @ 9:06 PM 12 Health Care Stocks Moving In Friday's After-Mar... Source: Benzinga Staff Writer

Jun 11, 2025 @ 9:07 PM FDA Expands AbbVie's Mavyret Label To Include Acut... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-3.84		$-3.84
Diluted EPS	$-3.84		$-3.84
Revenue	$65.32M		$65.32M
Gross Profit
Net Income / Loss	$-81.89M		$-81.89M
Operating Income / Loss	$-85.35M		$-85.35M
Cost of Revenue
Net Cash Flow	$-5.54M		$-5.54M
PE Ratio